7-Aug-2026
Stifel Nicolaus Sticks to Their Hold Rating for DENTSPLY SIRONA (XRAY)
TipRanks (Fri, 7-Aug 2:25 PM ET)
Evercore ISI Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
TipRanks (Fri, 7-Aug 8:46 AM ET)
BMO Capital Keeps Their Hold Rating on DENTSPLY SIRONA (XRAY)
TipRanks (Fri, 7-Aug 8:21 AM ET)
TipRanks (Fri, 7-Aug 6:10 AM ET)
Barclays Sticks to Their Sell Rating for DENTSPLY SIRONA (XRAY)
TipRanks (Fri, 7-Aug 4:37 AM ET)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Resmed (RMD) and DENTSPLY SIRONA (XRAY)
TipRanks (Fri, 7-Aug 3:10 AM ET)
Dentsply Sirona Non-GAAP EPS of $0.52 beats by $0.17, revenue of $898M beats by $8.16M
Seeking Alpha News (Thu, 6-Aug 5:04 PM ET)
Dentsply Sirona Reports Second Quarter 2026 Results
Globe Newswire (Thu, 6-Aug 4:01 PM ET)
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Wed, 29-Jul 9:13 AM ET)
Globe Newswire (Tue, 28-Jul 8:30 AM ET)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
Dentsply Sirona trades on the NASDAQ stock market under the symbol XRAY.
As of August 7, 2026, XRAY stock price declined to $12.12 with 7,942,147 million shares trading.
XRAY has a beta of 1.03, meaning it tends to be more sensitive to market movements. XRAY has a correlation of 0.06 to the broad based SPY ETF.
XRAY has a market cap of $2.43 billion. This is considered a Mid Cap stock.
Last quarter Dentsply Sirona reported $898 million in Revenue and $.52 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.17.
In the last 3 years, XRAY traded as high as $39.50 and as low as $9.41.
The top ETF exchange traded funds that XRAY belongs to (by Net Assets): IJH, IWM, VTI, VB, VBR.
XRAY has underperformed the market in the last year with a price return of -6.0% while the SPY ETF gained +23.5%. However, in the short term, XRAY had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.6% vs +6.0% return in SPY. But in the last 2 weeks, XRAY shares have been beat by the market, returning -6.3% compared to an SPY return of +4.6%.
XRAY support price is $12.72 and resistance is $13.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XRAY shares will trade within this expected range on the day.